The things that have been working, our commitment to cancer patients served in the ... Based on the most recent market data, the NGS market is growing 10% to 15% annually, and we believe we ...

For every type of cancer, archived tumor specimens and tissues obtained in clinical trials are comprehensively profiled using next-generation sequencing and ... Establish automated flow of ...

The molecular diagnostics market is experiencing significant growth driven by advancements in technology, increasing demand for personalized medicine, and the rising prevalence of chronic diseases.

Agilent Technologies Inc. (NYSE: A) announced today its participation at the American Association for Cancer Research (AACR) ...

An interdisciplinary research team has unveiled the world's first artificial intelligence (AI) model designed to classify ...

Once stolen, NGS data ... science, cancer research, etc. Making this process possible involves intertwined and complex steps—such as sample retrieval, prepping, sequencing, and analyzing ...

In the realm of medical diagnostics, blood lipid analysis and clinical diagnostic enzymes play a pivotal role in understanding and managing various health conditions. As key components in assessing ...

This approach streamlines the workflow ... generating more data per assay. In its recent clinical validation study using cfDNA samples from post-surgical ovarian and lung cancer patients ...